Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Lagarde

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Annals of Surgical Oncology|January 20, 2024
Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and EsophagectomyC J van der Zijden, P C van der Sluis, B Mostert, et al.
Best Practice & Research. Clinical Gastroenterology|December 16, 2018
Neoadjuvant chemoradiotherapy for resectable oesophageal cancerB M Eyck, B J van der Wilk, S M Lagarde, et al.
European Journal of Cancer Care|October 14, 2016
Development and feasibility of a web-based question prompt sheet to support information provision of health-related quality of life topics after oesophageal cancer surgeryM Jacobs, I Henselmans, D L Arts, et al.
The British Journal of Surgery|August 24, 2016
Role of omentectomy as part of radical surgery for gastric cancerE J Jongerius, D Boerma, K A Seldenrijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 23, 2026
[Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO-trial): a phase 3 multicentre stepped-wedge cluster-randomised noninferiority trial]B J van der Wilk, S S G Gangaram Panday, B M Eyck, et al.
The British Journal of Surgery|April 27, 2016
Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgeryJ Shapiro, D van Klaveren, S M Lagarde, et al.
Annals of Surgical Oncology|October 1, 2008
Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagusS M Lagarde, P E Ver Loren van Themaat, P D Moerland, et al.
Annals of Surgical Oncology|September 10, 2015
Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better OutcomesL E A M M Spierings, S M Lagarde, M G H van Oijen, et al.
Journal of Gastrointestinal Cancer|July 1, 2023
<sup>18</sup>F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction: Accuracy and Long-Term ImplicationsD C van der Aa, S S Gisbertz, M C J Anderegg, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 2, 2017
Treatment strategies in recurrent esophageal or junctional cancerR Butter, S M Lagarde, M G H van Oijen, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|January 20, 2024
Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and EsophagectomyC J van der Zijden, P C van der Sluis, B Mostert, et al.
Best Practice & Research. Clinical Gastroenterology|December 16, 2018
Neoadjuvant chemoradiotherapy for resectable oesophageal cancerB M Eyck, B J van der Wilk, S M Lagarde, et al.
European Journal of Cancer Care|October 14, 2016
Development and feasibility of a web-based question prompt sheet to support information provision of health-related quality of life topics after oesophageal cancer surgeryM Jacobs, I Henselmans, D L Arts, et al.
The British Journal of Surgery|August 24, 2016
Role of omentectomy as part of radical surgery for gastric cancerE J Jongerius, D Boerma, K A Seldenrijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 23, 2026
[Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO-trial): a phase 3 multicentre stepped-wedge cluster-randomised noninferiority trial]B J van der Wilk, S S G Gangaram Panday, B M Eyck, et al.
The British Journal of Surgery|April 27, 2016
Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgeryJ Shapiro, D van Klaveren, S M Lagarde, et al.
Annals of Surgical Oncology|October 1, 2008
Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagusS M Lagarde, P E Ver Loren van Themaat, P D Moerland, et al.
Annals of Surgical Oncology|September 10, 2015
Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better OutcomesL E A M M Spierings, S M Lagarde, M G H van Oijen, et al.
Journal of Gastrointestinal Cancer|July 1, 2023
<sup>18</sup>F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction: Accuracy and Long-Term ImplicationsD C van der Aa, S S Gisbertz, M C J Anderegg, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 2, 2017
Treatment strategies in recurrent esophageal or junctional cancerR Butter, S M Lagarde, M G H van Oijen, et al.
Pageof 5